Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 29451 - 29475 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Decitabine	Approved Investigational	CCDC18	343099	downregulated	decitabine results in decreased expression of CCDC18 mRNA	1p22.1	A21913
Decitabine	Approved Investigational	CCK	885	upregulated	decitabine results in increased expression of CCK mRNA	3p22.1	A21912
Decitabine	Approved Investigational	CCL20	6364	upregulated	decitabine results in increased expression of CCL20 mRNA	2q36.3	A21915
Decitabine	Approved Investigational	CCND1	595	downregulated	decitabine results in decreased expression of CCND1 mRNA	11q13.3	A21936 A21181
Decitabine	Approved Investigational	CCND1	595	upregulated	decitabine results in increased expression of CCND1 mRNA	11q13.3	A21937
Decitabine	Approved Investigational	CCNF	899	downregulated	decitabine results in decreased expression of CCNF mRNA	16p13.3	A21913
Decitabine	Approved Investigational	CCR2	729230	upregulated	decitabine results in increased expression of CCR2 mRNA	3p21.31	A21915
Decitabine	Approved Investigational	CD14	929	upregulated	decitabine results in increased expression of CD14 mRNA	5q31.3	A21912
Decitabine	Approved Investigational	CD24	100133941	upregulated	decitabine results in increased expression of CD24 mRNA	6q21	A20985
Decitabine	Approved Investigational	CD4	920	upregulated	decitabine results in increased expression of CD4 mRNA	12p13.31	A20985
Decitabine	Approved Investigational	CDC25C	995	downregulated	decitabine results in decreased expression of CDC25C mRNA	5q31.2	A21913
Decitabine	Approved Investigational	CDH1	999	upregulated	decitabine results in increased expression of CDH1 mRNA	16q22.1	A20778 A21938 A21845 A21939
Decitabine	Approved Investigational	CDH11	1009	downregulated	decitabine results in decreased expression of CDH11 mRNA	16q21	A21845
Decitabine	Approved Investigational	CDH2	1000	upregulated	decitabine results in increased expression of CDH2 mRNA	18q12.1	A21919
Decitabine	Approved Investigational	CDKN1A	1026	upregulated	decitabine results in increased expression of CDKN1A mRNA	6p21.2	A21940 A21941 A21845 A21942 A21623 A21937
Decitabine	Approved Investigational	CDKN1C	1028	upregulated	decitabine results in increased expression of CDKN1C mRNA	11p15.4	A20985
Decitabine	Approved Investigational	CDKN2A	1029	downregulated	decitabine results in decreased expression of CDKN2A mRNA	9p21.3	A21197
Decitabine	Approved Investigational	CDKN2A	1029	upregulated	decitabine results in increased expression of CDKN2A mRNA	9p21.3	A21919 A20778 A21942 A21943 A21944 A21945 A21918
Decitabine	Approved Investigational	CDKN2A	1029	upregulated	decitabine results in increased expression of CDKN2A mRNA alternative form	9p21.3	A21946
Decitabine	Approved Investigational	CDKN2B	1030	upregulated	decitabine results in increased expression of CDKN2B mRNA	9p21.3	A21947 A21930
Decitabine	Approved Investigational	CDKN2D	1032	upregulated	decitabine results in increased expression of CDKN2D mRNA	19p13.2	A21919 A21930
Decitabine	Approved Investigational	CDX1	1044	upregulated	decitabine results in increased expression of CDX1 mRNA	5q32	A21942
Decitabine	Approved Investigational	CDX2	1045	upregulated	[decitabine results in decreased methylation of CDX2 mRNA] which results in increased expression of CDX2 mRNA	13q12.2	A21948
Decitabine	Approved Investigational	CDX2	1045	upregulated	decitabine results in increased expression of CDX2 mRNA	13q12.2	A21948 A21942
Decitabine	Approved Investigational	CEACAM6	4680	upregulated	decitabine results in increased expression of CEACAM6 mRNA	19q13.2	A21942

Displaying entries 29451 - 29475 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability